about
Development of myeloproliferative disease in 12/15-lipoxygenase deficiencyLAB/NTAL facilitates fungal/PAMP-induced IL-12 and IFN-γ production by repressing β-catenin activation in dendritic cellsTherapeutic targeting of IL-6 trans signaling counteracts STAT3 control of experimental inflammatory arthritis.Cytomegalovirus-Specific IL-10-Producing CD4+ T Cells Are Governed by Type-I IFN-Induced IL-27 and Promote Virus Persistence.IL-27 Induced by Select Candida spp. via TLR7/NOD2 Signaling and IFN-β Production Inhibits Fungal Clearance.Interleukin-6 signaling drives fibrosis in unresolved inflammation.Inhibition of classic signaling is a novel function of soluble glycoprotein 130 (sgp130), which is controlled by the ratio of interleukin 6 and soluble interleukin 6 receptorImbalanced gp130 signalling in ApoE-deficient mice protects against atherosclerosis.Interleukin-10 regulates the inflammasome-driven augmentation of inflammatory arthritis and joint destructionTranslocation and insecticidal activity of Bacillus thuringiensis living inside of plants.Cytopathological effects of Bacillus sphaericus Cry48Aa/Cry49Aa toxin on binary toxin-susceptible and -resistant Culex quinquefasciatus larvae.Tertiary Lymphoid Structures in Cancer: Drivers of Antitumor Immunity, Immunosuppression, or Bystander Sentinels in Disease?IL-27 - a double agent in the IL-6 family.In Vivo Models for Inflammatory Arthritis.Hyperactive gp130/STAT3-driven gastric tumourigenesis promotes submucosal tertiary lymphoid structure development.Loss of CD4+ T cell IL-6R expression during inflammation underlines a role for IL-6 trans signaling in the local maintenance of Th17 cells.CD28- Cells Are Increased in Early Rheumatoid Arthritis and Are Linked With Cytomegalovirus Status
P50
Q28269503-5919F039-63D6-4AC0-BFD1-E7BE13C2E196Q34722541-E259F048-04A2-446D-9912-12A73D3AE26DQ34910849-4DF9C988-7203-49FB-B6F9-58418056D161Q36214992-03FF501C-AE16-4E13-923D-D0E862A682E3Q37015050-3FD44F6F-6FDB-4FA7-828B-A8A6A64FD348Q37572817-CAFF634D-7E92-42E5-80E9-6579B77507DCQ39459586-B321D34A-B7F6-42C5-850A-0541F13EB358Q41578578-CC3CB601-23E4-4DD2-B086-1F4D96BA8FAEQ41772150-DEBF7554-E600-4406-86CE-388D979599F4Q41905236-F9BFAC2E-1AA5-48D8-B482-903226EEFBC8Q43097273-8A9DA376-6755-4C7A-942D-C74B3CF45499Q47194123-3120C0A9-A92F-40E2-8B70-D7F44B56A471Q50045633-69489C00-E67B-4453-9A4D-73F67BB5A8AAQ50097642-ECF4B24A-0A6A-407B-97CD-3DB00DF5995DQ50125239-635249AE-4EF5-41FC-A8D4-19F36D814CEFQ51887698-7BD2F78C-F727-44AD-A20C-B7C7D4977C6EQ95300266-C663E626-F673-4706-A227-861A63C34808
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Gareth W Jones
@ast
Gareth W Jones
@en
Gareth W Jones
@es
Gareth W Jones
@nl
type
label
Gareth W Jones
@ast
Gareth W Jones
@en
Gareth W Jones
@es
Gareth W Jones
@nl
prefLabel
Gareth W Jones
@ast
Gareth W Jones
@en
Gareth W Jones
@es
Gareth W Jones
@nl
P108
P106
P21
P31
P496
0000-0002-0125-4841